2009年肺癌解读幻灯片.pptVIP

非小细胞肺癌治疗进展  Competition in NSCLC Competition in NSCLC Competition in NSCLC E4599 and Avail 入组病人的基本情况 研究结果：主要研究终点 Competition in NSCLC Competition in NSCLC Competition in NSCLC 肺癌个体化治疗，我们的选择应该是…… 我们的选择应该是…… 谢谢大家 Cisplatin 75 mg/m2 day 1 plus Gemcitabine 1250 mg/m2 days 1 8 RandomizationFactors Stage PS Gender Histo vs cyto Brain mets R Cisplatin 75 mg/m2 day 1 plus Pemetrexed 500 mg/m2 day 1 Vitamin B12, folate, and dexamethasone given in both arms Each cycle repeated q3 weeks up to 6 cycles Scagliotti et al J Clin Oncol, 26, 3543-3551, 2008 Primary endpoint: survival; non-inferi